The use of histamine H2 receptor antagonists was associated with preserved left ventricular morphological indices and a lower risk of incident heart failure [27]; likewise, a small (n = 50) randomised controlled trial in heart failure patients found that famotidine, an H2 receptor antagonist, improved heart failure symptoms and decreased heart failure readmissions [28]. This evidence concerns the gene HRH2 and heart failure.